by The Macrophage Marker Market is estimated to be valued at US$ 256.2 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The macrophage marker market comprises various products such as antibodies, ELISPOT assay kits, flow cytometry assay kits, and western blot kits that are used to identify and study macrophages. Macrophages play a vital role in innate immunity by engulfing and digesting foreign substances, cellular debris, and pathogens. Macrophage markers help in distinguishing monocytes from macrophages and analyzing macrophage polarization and subpopulations. Some commonly studied macrophage markers include CD68, CD14, CD163, inducible nitric oxide synthase, CD206, CD80, and HLA-DR.
Market Dynamics:
Increasing R&D investments in immunology and use of cell-based therapies are expected to boost the market growth over the forecast period. For instance, according to a report by National Center for Biotechnology Information, United States, the global funding for immunological research increased from US$ 12 billion in 2010 to US$ 20.2 billion in 2017. Additionally, the burgeoning application of macrophage markers in precision and individualized medicine is also fueling the market growth. Macrophage markers help in identifying potential treatment responsive populations and distinguishing disease associated macrophages from healthy macrophages. For example, targeting CD163-expressing macrophages can help in treating inflammatory diseases.
Segment Analysis
The global Macrophage Marker market is dominated by the Human primary segment which captures over 35% of the total market share. This segment is dominating as human-based research helps gain deeper insights into macrophage biology and immunology which assists in developing effective treatments for various chronic diseases.
PEST Analysis
Political: The government support in terms of funding for research activities focusing on macrophage biology is helping drive the market growth. However, stringent regulations may increase compliance costs for market players.
Economic: Rising healthcare spending coupled with growing R&D investments from pharmaceutical and biotechnology companies is fueling the demand for macrophage markers.
Social: Increasing prevalence of chronic diseases like cancer and awareness regarding their early diagnosis is positively impacting the market expansion.
Technological: Advancements in microscope imaging technologies and development of high-specificity antibodies are enabling accurate analysis of macrophage functions, thereby supporting the market revenue.
Key Takeaways
The Global Macrophage Marker Market Size is expected to witness high growth, exhibiting CAGR of 6.5% over the forecast period, due to increasing research on chronic diseases worldwide. The North America region dominated the global market in 2023 and is expected to maintain its lead over the forecast period owing to presence of major market players and growing research expenditure in the region.
Regional analysis
The North America region accounted for over 35% of the global Macrophage Marker market share in 2023 driven by rising prevalence of chronic diseases and growing research funding in the US and Canada. Asia Pacific is anticipated to showcase the fastest growth rate during the forecast period owing to increasing healthcare investments, emergence of regional bioclusters and expanding biopharmaceutical industry in countries like India and China.
Key players
Key players operating in the Macrophage Marker market are Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., and MBL International Corporation.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
